Abstract: A touch device includes: a touch panel including a plurality of X-touch lines and a plurality of Y-touch lines crossing each other; an X-touch driving part simultaneously transmitting at least two of a plurality of X-self signals to the plurality of X-touch lines and sequentially transmitting a plurality of X-mutual signals to the plurality of X-touch lines; and a Y-touch driving part simultaneously transmitting at least two of a plurality of Y-self signals to the plurality of Y-touch lines and transmitting at least two of a plurality of Y-mutual signals to the plurality of Y-touch lines.

Abstract: A touch device includes: a touch panel including a plurality of X-touch lines and a plurality of Y-touch lines crossing each other; an X-touch driving part simultaneously transmitting at least two of a plurality of X-self signals to the plurality of X-touch lines and sequentially transmitting a plurality of X-mutual signals to the plurality of X-touch lines; and a Y-touch driving part simultaneously transmitting at least two of a plurality of Y-self signals to the plurality of Y-touch lines and transmitting at least two of a plurality of Y-mutual signals to the plurality of Y-touch lines.

Abstract: A preparation of a kind of 20(R)-ginsenoside Rg3 medicinal composition aqueous solution containing ginsenoside Rg3 0.5˜10 mg/ml: add 0.1-5% of ginsenoside solution to 0.1˜30% of adjuvant A, B{circle around (1)}{circle around (2)}{circle around (5)} at the temperature of 40˜100° C., the ratio of these two is 1:1˜300, add water after the solvent is recycled under reduced pressure; another kind of 20(R)-ginsenoside Rg3 medicinal composition aqueous solution contains 0.1˜2 mg/ml of 20 (R) of the ginsenoside Rg3, the preparation: add 0.1˜5% of ginsenoside solution to 20˜65% of adjuvant B{circle around (3)}{circle around (4)} at the temperature of 60˜100° C., main material to adjuvant B=1:100˜400, add water after the solvent is recycled under reduced pressure.